A library of induced pluripotent stem cells from clinically well-characterized, diverse healthy human individuals
暂无分享,去创建一个
M. Mahajan | E. Schadt | R. Iyengar | R. Sebra | J. Goldfarb | V. Najfeld | M. Birtwistle | J. Kovacic | C. Schaniel | E. Sobie | K. Beaumont | E. Azeloglu | G. Jayaraman | Bin Hu | S. Schürer | J. Hansen | K. Michelis | N. Dubois | David M. Gonzalez | Seth I. Berger | Y. Xiong | J. Garg | Moara Machado | R. Dariolli | A. S. Yadaw | H. Weerahandi | Priyanka Dhanan | S. D'Souza | Colleen S. Surlyn | D. Vidović | Teeya Raghunandan | Bino Mathew | Joseph Tripodig | Marc Miller | N. Tangirala | David Thomas | Yuguang Xiong | Gomathi Jayaraman | Joseph Goldfarb | J. Hansen | Jalaj Garg
[1] P. Clements,et al. Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue Format , 2020, Stem cell reports.
[2] Derek C. Liberti,et al. A Highly Phenotyped Open Access Repository of Alpha-1 Antitrypsin Deficiency Pluripotent Stem Cells , 2020, Stem cell reports.
[3] G. Vassalli,et al. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes. , 2020, Biochimica et biophysica acta. Molecular cell research.
[4] Vasileios Stathias,et al. LINCS Data Portal 2.0: next generation access point for perturbation-response signatures , 2019, Nucleic Acids Res..
[5] K. Frazer,et al. Association of Human iPSC Gene Signatures and X Chromosome Dosage with Two Distinct Cardiac Differentiation Trajectories , 2019, Stem cell reports.
[6] S. Haggarty,et al. A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies , 2019, Stem cell reports.
[7] Ravi Iyengar,et al. The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations. , 2017, Cell systems.
[8] Vasileios Stathias,et al. Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data , 2017, Nucleic Acids Res..
[9] G. Keller,et al. Human Pluripotent Stem Cell-Derived Atrial and Ventricular Cardiomyocytes Develop from Distinct Mesoderm Populations. , 2017, Cell stem cell.
[10] Ricardo J. Miragaia,et al. Gene expression variability across cells and species shapes innate immunity , 2017, Nature.
[11] Davis J. McCarthy,et al. Common genetic variation drives molecular heterogeneity in human iPSCs , 2017, Nature.
[12] Gaurav Pandey,et al. Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity. , 2017, Cell stem cell.
[13] Christopher M. DeBoever,et al. iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types , 2017, Stem cell reports.
[14] Bing Ren,et al. Large-Scale Profiling Reveals the Influence of Genetic Variation on Gene Expression in Human Induced Pluripotent Stem Cells. , 2017, Cell stem cell.
[15] P. Sebastiani,et al. A Comprehensive, Ethnically Diverse Library of Sickle Cell Disease-Specific Induced Pluripotent Stem Cells , 2017, Stem cell reports.
[16] Helen E. Parkinson,et al. The human-induced pluripotent stem cell initiative—data resources for cellular genetics , 2016, Nucleic Acids Res..
[17] M. Snyder,et al. Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells. , 2016, JCI insight.
[18] L Zhang,et al. Racial/ethnic differences in drug disposition and response: Review of recently approved drugs , 2015, Clinical pharmacology and therapeutics.
[19] Robert Passier,et al. Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology , 2015, EMBO molecular medicine.
[20] O. Abilez,et al. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. , 2014, Journal of the American College of Cardiology.
[21] S. Kattman,et al. The generation of the epicardial lineage from human pluripotent stem cells , 2014, Nature Biotechnology.
[22] Daniel J. Gaffney,et al. Genetic Background Drives Transcriptional Variation in Human Induced Pluripotent Stem Cells , 2014, PLoS genetics.
[23] J. Loring,et al. Genomic Instability in Pluripotent Stem Cells: Implications for Clinical Applications* , 2013, The Journal of Biological Chemistry.
[24] Deanna M. Church,et al. ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..
[25] M. Suematsu,et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. , 2013, Cell stem cell.
[26] Julie V. Harness,et al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. , 2012, Cell stem cell.
[27] Dong Ryul Lee,et al. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage , 2011, Nature Biotechnology.
[28] Gordon Keller,et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells , 2011, Nature Biotechnology.
[29] Jing Zhang,et al. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals , 2011, Cell Research.
[30] M. Newton,et al. Karyotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells , 2011, Nature Biotechnology.
[31] Gordon Keller,et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. , 2011, Cell stem cell.
[32] Alexander Meissner,et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.
[33] Yoav Mayshar,et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. , 2010, Cell stem cell.
[34] M. Hasegawa,et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.
[35] George Q. Daley,et al. Reprogramming of human somatic cells to pluripotency with defined factors , 2008, Nature.
[36] Shulan Tian,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[37] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[38] T. Graf. Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors. , 2007 .
[39] Celeste M Condit,et al. Genetic research and health disparities. , 2004, JAMA.
[40] A. Bishop,et al. Embryonic stem cells , 2004, Cell proliferation.
[41] David B. Goldstein,et al. Population genetic structure of variable drug response , 2001, Nature Genetics.
[42] 遠山 周吾. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes , 2013 .
[43] D. Mattison,et al. Sex Differences in Pharmacokinetics and Pharmacodynamics , 2009, Clinical pharmacokinetics.